Andra AP fonden Acquires 4,100 Shares of Laboratory Corp. of America Holdings (NYSE:LH)

Share on StockTwits

Andra AP fonden grew its position in shares of Laboratory Corp. of America Holdings (NYSE:LH) by 9.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 46,100 shares of the medical research company’s stock after buying an additional 4,100 shares during the quarter. Andra AP fonden’s holdings in Laboratory Corp. of America were worth $8,007,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Migdal Insurance & Financial Holdings Ltd. grew its position in shares of Laboratory Corp. of America by 7,033.3% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 642 shares of the medical research company’s stock valued at $115,000 after purchasing an additional 633 shares in the last quarter. Fort L.P. purchased a new position in shares of Laboratory Corp. of America during the 2nd quarter valued at $118,000. Squar Milner Financial Services LLC purchased a new position in shares of Laboratory Corp. of America during the 2nd quarter valued at $150,000. LeJeune Puetz Investment Counsel LLC purchased a new position in shares of Laboratory Corp. of America during the 2nd quarter valued at $166,000. Finally, Mount Yale Investment Advisors LLC purchased a new position in shares of Laboratory Corp. of America during the 1st quarter valued at $155,000. 91.99% of the stock is currently owned by hedge funds and other institutional investors.

LH has been the subject of a number of recent analyst reports. SunTrust Banks reissued a “buy” rating and issued a $220.00 price target on shares of Laboratory Corp. of America in a research note on Friday, July 20th. Canaccord Genuity reissued a “buy” rating and issued a $200.00 price target on shares of Laboratory Corp. of America in a research note on Tuesday, July 24th. Jefferies Financial Group reissued a “neutral” rating and issued a $180.00 price target on shares of Laboratory Corp. of America in a research note on Thursday, July 26th. Mizuho reaffirmed a “hold” rating and set a $189.00 price objective on shares of Laboratory Corp. of America in a research note on Thursday, July 26th. Finally, Deutsche Bank lowered their price objective on shares of Laboratory Corp. of America from $195.00 to $190.00 and set a “hold” rating for the company in a research note on Monday, August 20th. Eight analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $192.19.

In other news, Director Kerrii B. Anderson sold 3,700 shares of the stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $163.29, for a total transaction of $604,173.00. Following the sale, the director now owns 21,795 shares in the company, valued at $3,558,905.55. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.73% of the company’s stock.

LH traded down $1.31 during midday trading on Friday, reaching $170.15. The company’s stock had a trading volume of 682,934 shares, compared to its average volume of 930,082. The stock has a market cap of $17.25 billion, a PE ratio of 17.72, a price-to-earnings-growth ratio of 1.62 and a beta of 1.00. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.44 and a current ratio of 1.55. Laboratory Corp. of America Holdings has a 1 year low of $147.70 and a 1 year high of $190.35.

Laboratory Corp. of America (NYSE:LH) last announced its quarterly earnings data on Wednesday, October 24th. The medical research company reported $2.74 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.88 by ($0.14). The business had revenue of $2.83 billion during the quarter, compared to analysts’ expectations of $2.84 billion. Laboratory Corp. of America had a return on equity of 17.13% and a net margin of 13.27%. Laboratory Corp. of America’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the company posted $2.46 EPS. Equities research analysts predict that Laboratory Corp. of America Holdings will post 11.33 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Andra AP fonden Acquires 4,100 Shares of Laboratory Corp. of America Holdings (NYSE:LH)” was first published by BBNS and is the sole property of of BBNS. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://baseballnewssource.com/2018/11/10/andra-ap-fonden-purchases-4100-shares-of-laboratory-corp-of-america-holdings-lh/2847107.html.

About Laboratory Corp. of America

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. It offers a range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, prostate-specific antigen, tests for sexually-transmitted diseases, hepatitis C tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

Recommended Story: Fundamental Analysis and Individual Investors

Institutional Ownership by Quarter for Laboratory Corp. of America (NYSE:LH)

Receive News & Ratings for Laboratory Corp. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.